Susceptibility of Chlamydia pneumoniae to oral agents commonly used in the treatment of respiratory infection. - Suppr | 超能文献

Susceptibility of Chlamydia pneumoniae to oral agents commonly used in the treatment of respiratory infection.

作者信息

Beale A S, Masson N D

出版信息

J Antimicrob Chemother. 1994 Dec;34(6):1072-4. doi: 10.1093/jac/34.6.1072.

DOI:10.1093/jac/34.6.1072

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Susceptibility of Chlamydia pneumoniae to oral agents commonly used in the treatment of respiratory infection.

J Antimicrob Chemother. 1994 Dec;34(6):1072-4. doi: 10.1093/jac/34.6.1072.

2

In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae.新型8-甲氧基喹诺酮BAY 12-8039对肺炎衣原体的体外活性

Antimicrob Agents Chemother. 1998 Apr;42(4):951-2. doi: 10.1128/AAC.42.4.951.

3

Treatment with appropriate antibiotic therapy in community-acquired respiratory tract infections.社区获得性呼吸道感染的适当抗生素治疗

Am J Manag Care. 2004 Oct;10(12 Suppl):S381-8.

4

Doxycycline in community acquired respiratory infections--a perspective of 1990's.

J Assoc Physicians India. 1999 Mar;47(3):326-31.

5

[Oral beta-lactam antibiotics in the treatment of respiratory tract infections].[口服β-内酰胺类抗生素治疗呼吸道感染]

Antibiot Khimioter. 2001;46(7):27-33.

6

A reverse transcriptase-PCR based assay for in-vitro antibiotic susceptibility testing of Chlamydia pneumoniae.一种基于逆转录聚合酶链反应的肺炎衣原体体外抗生素敏感性检测方法。

J Antimicrob Chemother. 1996 Apr;37(4):677-85. doi: 10.1093/jac/37.4.677.

7

Eradication of Chlamydia pneumoniae from coronary artery endothelium.

Cardiovasc Drugs Ther. 2002 Mar;16(2):167; author reply 169. doi: 10.1023/a:1015765702384.

8

In vitro activity of nemonoxacin, a novel nonfluorinated quinolone antibiotic, against Chlamydia trachomatis and Chlamydia pneumoniae.新型非氟喹诺酮类抗生素奈诺沙星对沙眼衣原体和肺炎衣原体的体外活性

Antimicrob Agents Chemother. 2014;58(3):1800-1. doi: 10.1128/AAC.02263-13. Epub 2013 Dec 23.

9

In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae.新型抗菌酮内酯类药物塞曲霉素对肺炎衣原体的体外活性

J Antimicrob Chemother. 2003 Sep;52(3):497-9. doi: 10.1093/jac/dkg371. Epub 2003 Aug 13.

10

In vitro activity of garenoxacin against recent clinical isolates of Chlamydia pneumoniae.加替沙星对近期肺炎衣原体临床分离株的体外活性

Int J Antimicrob Agents. 2003 Jun;21(6):578-80. doi: 10.1016/s0924-8579(03)00061-x.

引用本文的文献

1

In vitro susceptibilities of Chlamydia pneumoniae isolates from German patients and synergistic activity of antibiotic combinations.德国患者肺炎衣原体分离株的体外药敏性及抗生素联合用药的协同活性。

Antimicrob Agents Chemother. 1999 Jul;43(7):1808-10. doi: 10.1128/AAC.43.7.1808.

2

Relevance of Chlamydia pneumoniae murine pneumonitis model to evaluation of antimicrobial agents.肺炎衣原体小鼠肺炎模型在抗菌药物评价中的相关性。

Antimicrob Agents Chemother. 1995 Sep;39(9):1959-64. doi: 10.1128/AAC.39.9.1959.